Report: Oxford Bioscience Has New Fund

Xconomy Boston — 

The Boston-based venture firm Oxford Bioscience Partners has held the first $66 million close of its sixth fund, Dan Primack of Fortune writes today. During his Thomson Reuters days, Primack caused a stir at Oxford when he wrote an obituary of sorts on the venture firm along with other VCs that he believed were no longer making new investments. Today, he writes that Oxford, a life sciences-focused firm, has raised the first part of its new fund from the government of South Korea and the city government of Seoul.